NEW YORK (TheStreet) -- Reporting after hours today, Groupon (GRPN) and Priceline.com (PCLN) are abuzz in the growing Internet commerce business. Meanwhile, former Dow component and provider of computing and imaging products Hewlett Packard (HPQ) is in the midst of a turnaround story in a waning personal computer environment.
Next week, we'll look at how traders and and investors reacted to this week's beats, misses and guidance.
These eight companies report results after hour today:
Express Scripts (ESRX) ($76.38): Analysts expect the pharmacy benefit management company to report earnings of $1.12 a share. The stock set an all-time intraday high at $77.40 on Tuesday well above its 200-day simple moving average at $65.82. The weekly chart is positive but overbought with its five-week modified moving average at $73.56 and its 200-week SMA at $55.66. The stock has a gain of 34.1% over the last 12 months. My monthly value level is $71.76 with quarterly and weekly risky levels at $77.15 and $78.37.
Groupon ($10.02): Analysts expect the Internet commerce company to report a loss of a penny a share. The stock set its 2014 high at $12.42 on Jan. 6 then traded down to $9.90 on Jan. 27 staying above its 200-day SMA at $9.68. The weekly chart is negative with its five-week MMA at $10.58. The stock has a gain of 69.1% over the last 12 months. My monthly risky level is $12.23.
Hewlett Packard ($29.45): Analysts expect the computer and imaging giant to report earnings of 85 cents a share. The stock set a multiyear intraday high at $30.13 on Jan. 22 then declined to $27.89 on Feb. 4 holding its 50-day SMA and is well above its 200-day SMA at $25.21. The weekly chart is positive but overbought with the five-week MMA at $28.78 and the 200-week SMA at $29.17. The stock has a gain of 74.4% over the last 12 months. Monthly and semiannual value levels are $27.03 and $24.95 with a weekly risky level at $30.13.
Nordstrom (JWN) ($58.88): Analysts expect the upscale retailer to report earnings of $1.33 a share. The stock has been below its 200-day SMA at $59.49 since Jan. 23 with a 2014 low at $54.90 on Feb. 5. The weekly chart is neutral with its five-week MMA at $59.23 and its 200-week SMA at $50.09. The stock has a gain of 4.3% over the last 12 months. My annual value level is $52.86 with a monthly pivot at $59.51 and annual, quarterly and semiannual risky levels at $61.71, $63.41 and $64.19.